$UBX
Unity Biotechnology Inc
PRICE
$0.6133 ▼-36.78%
Last Close
VOLUME
30,846,235
DAY RANGE
0.94 - 1.27
52 WEEK
0.55 - 3.64
Key Metrics
Market Cap
95.42 M
Beta
1.86
Avg. Volume
6.53 M
Shares Outstanding
69.65 M
Yield
0%
Public Float
0
Next Earnings Date
2022-11-09
Next Dividend Date
Company Information
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.
CEO: Anirvan Ghosh
Website: unitybiotechnology.com
HQ: 3280 Bayshore Blvd Brisbane, 94005-1028 California
Related News